J Immunol Methods 2010,356(1–2):1–5.PubMedCentralPubMedCrossRef 34. Bae T, Schneewind O: Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 2006,55(1):58–63.PubMedCrossRef 35. Monk IR, Shah IM,

Xu M, Tan MW, Foster TJ: Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis . MBio 2012,3(2):e00277–00211.PubMedCentralPubMedCrossRef 36. Li MZ, Elledge SJ: Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC. Nat Methods 2007,4(3):251–256.PubMedCrossRef 37. Howden BP, McEvoy CR, Allen DL, Chua K, Gao W, Harrison PF, Bell PCI-32765 ic50 J, Coombs G, Bennett-Wood V, Porter JL, et al.: Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog 2011,7(11):e1002359.PubMedCentralPubMedCrossRef 38. Rumble SM, Lacroute P, Dalca AV, Fiume M, Sidow

Elacridar ic50 A, Selleckchem 3-deazaneplanocin A Brudno M: SHRiMP: accurate mapping of short color-space reads. PLoS Comput Biol 2009,5(5):e1000386.PubMedCentralPubMedCrossRef 39. David M, Dzamba M, Lister D, Ilie L, Brudno M: SHRiMP2: sensitive yet practical SHort Read Mapping. Bioinformatics 2011,27(7):1011–1012.PubMedCrossRef 40. Robinson MD, McCarthy DJ, Smyth GK: edgeR: a Bioconductor package for differential Cobimetinib in vivo expression analysis of digital

gene expression data. Bioinformatics 2010,26(1):139–140.PubMedCrossRef Competing interest No author has any competing interests to declare. Authors’ contributions Conceived the project, TPS, BPH, KYLC, JKD; performed the experiments, KYLC, IRM, YHL, JLP, GWC, JS, KLT; analysed the data, KYLC, YHL, TPS, BPH, TS, KLT; wrote the manuscript, KYLC, BPH, TPS. All authors read and approved the final manuscript.”
“Background Nicotinamide adenine dinucleotide (NAD+) and NAD+ phosphate (NADP+) are two of the most important coenzymes in cells. They act as either electron donors or electron acceptors in more than 300 enzymatically catalyzed oxidoreductions [1, 2]. NAD+ also plays an essential role in producing ATP, and is involved in various cellular processes as a substrate for a number of degradation enzymes [3–9]. Abnormal regulation of NAD+ metabolism may result in or is associated with serious metabolic disorders and diseases, such as diabetes, cancers, neurological disorders and cardiovascular disease [2, 10–17]. Furthermore, the disruption of NAD+ synthesis can cause growth suppression and cell death [18–21].